Comprehensive Medical Weight Loss Denver
Get the latest developments in medical weight loss at Clinical Nutrition Center in Denver, Colorado, a doctor-supervised weight loss center. Ethan Lazarus, MD is a medical weight loss doctor helping patients achieve long-term weight control.
If you’re starting a GLP-1 like semaglutide or tirzepatide here in Denver, the question I hear most isn’t “how much will I lose.” It’s “what will it feel like?” Fair. Nobody wants to walk in blind. Roughly 40 to 70…
By Dr. Ethan Lazarus, MDBoard-Certified in Obesity Medicine and Family MedicineClinical Nutrition Center, Greenwood Village, CO Three state Medicaid programs have carved weight-loss medications out of coverage — and Colorado is on the list by default, not by design. Massachusetts…
*A new Gallup poll puts the U.S. adult obesity rate at 36.4% — down from a peak of 39.9% in 2022. One in nine Americans now takes a GLP-1 medication. A Denver obesity physician takes stock.* — In 2022, 39.9%…
You’ve decided to pursue GLP-1 therapy—smart move. But now comes the fork in the road: needle or pill? If your primary care doctor just said “pick whichever you prefer,” they weren’t wrong, but they also weren’t telling you the whole…
Eight-five percent. That’s how many people stop taking their GLP-1 medication within two years. Not because the drugs stopped working. Not because they got lazy. Because the approach was wrong from the start. GLP-1 medications—Ozempic, Wegovy, Zepbound, Foundayo and their…
GLP-1 Medications and Cancer Risk: What a New Study Shows Published May 26, 2026 | Dr. Ethan Lazarus, MD A new study adds to a growing body of evidence that GLP-1 receptor agonists may do more than lower blood sugar…
A patient came in last month frustrated. She’d been on a GLP-1 medication for four months, had lost 18 pounds — and yet her body composition told a different story. She’d dropped muscle, not just fat. When I asked her…
For years, the standard answer was: eat less, move more. If that didn’t work, you didn’t try hard enough. We know better now. GLP-1 medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) work — in clinical trials, they work…
New Phase 3 Data: Survodutide Delivers 16.6% Weight Loss — Dual GLP-1/Glucagon Agonist Shows Metabolic Benefits Beyond the Scale The SYNCHRONIZE-1 Phase 3 trial results are in — and they’re worth your attention. Survodutide (BI 456906), Boehringer Ingelheim’s novel dual…
Amazon just entered the weight loss drug business. And if you’ve been watching the GLP-1 space, you probably saw it coming. On April 21, 2026, Amazon launched a GLP-1 Management Program through Amazon One Medical — combining virtual visits, prescription…
